With hundreds of exhibiting companies and thousands of attendees, NACE Automechanika Atlanta is set to lead the industry in a showcase of the latest technology covering the entire spectrum of the automotive aftermarket. Join us August 8–10 for the largest U.S. trade show dedicated to high-end technical and management-related training for automotive collision and service repair shops. Mitchell will once again be attending NACE as an exhibitor with an interactive exhibit booth. Those visiting Mitchell’s booth will have the opportunity to be one of the first to demo the latest Mitchell solutions for the repair industry. We look forward to seeing you on the show floor! Need to schedule a meeting with a sales representative? Contact us today.
More stories
Plugged-In: EV Collision Insights Q2 2024
Claims frequency for repairable, collision-damaged battery electric vehicles (BEVs) rose to 2.5% in the U.S. and 3.94% in Canada in Q2 2024—a year-over-year increase of 45% and 39% respectively. According to the Alliance for Automotive Innovation, EVs represented 9.3% of new U.S. light-duty vehicle sales in Q1 2024, down from 10.2% in Q4 2023. Similarly, in Canada BEV sales fell to 9.2% last quarter, down from 10% in Q4 2023.
An Overlooked Essential: Hospital Discharge Planning in Workers’ Compensation
In a recent article, Jim Begg, Vice President of National Accounts for Apricus, highlights the critical role of effective discharge planning in helping patients recover swiftly and safely.
Bridging the Gap for New Adjusters with Innovative Tools
Streamline your claims process and support your team with our cutting-edge solutions.
SEMA 2024
The SEMA Show is the premier destination for manufacturers and buyers looking to discover thousands of the latest innovations in the automotive aft
New Trends in Opioids and Pain Management
Despite decreases in utilization and cost per claim, opioids remain the No. 1 drug class in Enlyte’s 2024 Drug Trends Report. However, due to concerns with safety and overutilization, increased focus on usage guidelines as well as alternatives to pain management are gaining momentum — including those whose active ingredients drive from things you might not imagine, like pufferfish, cacti and chili peppers. Enlyte’s Nikki Wilson explores this and more in our Part 3 drug trends analysis.
Ask The Pharmacist: GLP-1 Drugs in Workers’ Compensation
Glucagon-like peptide 1 (GLP-1) receptor agonists medications, originally designed for diabetes management, have skyrocketed in popularity over the past year as effective drugs for weight loss and obesity.